Form 4: Aquestive Therapeutics SVP, Operations, Cassie Jung Reports Stock Transactions
SEC Form 4 Filing
Cassie Jung, SVP of Operations at Aquestive Therapeutics, reports disposition of shares to cover tax obligations related to vesting Restricted Stock Units.
Summary
- Cassie Jung, SVP of Operations at Aquestive Therapeutics, Inc. [AQST], reported transactions involving the company's common stock.
- On March 9, 2024, and March 10, 2024, Jung disposed of 8,300 and 1,132 shares, respectively, at a price of $4.88 per share to cover tax obligations related to vesting Restricted Stock Units (RSUs).
- Following these transactions, Jung directly owns 237,754 shares of Aquestive Therapeutics common stock.
- Jung also indirectly owns 2,000 shares through a spouse and 44 shares through a spouse's IRA.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document reports routine stock transactions related to executive compensation.
Industry Context
This is a routine disclosure related to executive compensation and tax obligations, common in publicly traded companies.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 03/09/2024 | Disposition of 8,300 shares of common stock to cover tax obligations. |
| 03/10/2024 | Disposition of 1,132 shares of common stock to cover tax obligations. |
| 03/12/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.